Connection

Federica del Monte to Humans

This is a "connection" page, showing publications Federica del Monte has written about Humans.
Connection Strength

0.393
  1. Phosphorylated cofilin-2 is more prone to oxidative modifications on Cys39 and favors amyloid fibril formation. Redox Biol. 2020 10; 37:101691.
    View in: PubMed
    Score: 0.027
  2. Heart and Brain: Complex Relationships for Left Ventricular Dysfunction. Curr Cardiol Rep. 2020 06 23; 22(8):72.
    View in: PubMed
    Score: 0.027
  3. The more we learn, the less we know: A novel cardiac mechanism of brain damage. J Mol Cell Cardiol. 2019 03; 128:158-159.
    View in: PubMed
    Score: 0.025
  4. A? Amyloid Pathology Affects the Hearts of Patients?With?Alzheimer's Disease: Mind?the Heart. J Am Coll Cardiol. 2016 Dec 06; 68(22):2395-2407.
    View in: PubMed
    Score: 0.021
  5. Cofilin-2 phosphorylation and sequestration in myocardial aggregates: novel pathogenetic mechanisms for idiopathic dilated cardiomyopathy. J Am Coll Cardiol. 2015 Mar 31; 65(12):1199-1214.
    View in: PubMed
    Score: 0.019
  6. Protein post-translational modifications and misfolding: new concepts in heart failure. Proteomics Clin Appl. 2014 Aug; 8(7-8):534-42.
    View in: PubMed
    Score: 0.018
  7. Protein aggregates and novel presenilin gene variants in idiopathic dilated cardiomyopathy. Circulation. 2010 Mar 16; 121(10):1216-26.
    View in: PubMed
    Score: 0.013
  8. Intracellular devastation in heart failure. Heart Fail Rev. 2008 Jun; 13(2):151-62.
    View in: PubMed
    Score: 0.012
  9. Protein unfolding in cardiomyopathies. Heart Fail Clin. 2005 Jul; 1(2):237-50.
    View in: PubMed
    Score: 0.010
  10. Targeted gene transfer in heart failure: implications for novel gene identification. Curr Opin Mol Ther. 2004 Aug; 6(4):381-94.
    View in: PubMed
    Score: 0.009
  11. Transcriptional changes following restoration of SERCA2a levels in failing rat hearts. FASEB J. 2004 Sep; 18(12):1474-6.
    View in: PubMed
    Score: 0.009
  12. Targeting calcium cycling proteins in heart failure through gene transfer. J Physiol. 2003 Jan 01; 546(Pt 1):49-61.
    View in: PubMed
    Score: 0.008
  13. Dissociation of hypertrophic growth from changes in myocyte contractile function. J Card Fail. 2002 Dec; 8(6 Suppl):S415-20.
    View in: PubMed
    Score: 0.008
  14. Defects in calcium control. J Card Fail. 2002 Dec; 8(6 Suppl):S421-31.
    View in: PubMed
    Score: 0.008
  15. Targeting phospholamban by gene transfer in human heart failure. Circulation. 2002 Feb 26; 105(8):904-7.
    View in: PubMed
    Score: 0.008
  16. Is heart failure with preserved ejection fraction a 'dementia' of the heart? Heart Fail Rev. 2022 03; 27(2):587-594.
    View in: PubMed
    Score: 0.007
  17. The long and winding road to target protein misfolding in cardiovascular diseases. Eur J Clin Invest. 2021 May; 51(5):e13504.
    View in: PubMed
    Score: 0.007
  18. Primary cilia defects causing mitral valve prolapse. Sci Transl Med. 2019 05 22; 11(493).
    View in: PubMed
    Score: 0.006
  19. Getting to the Heart of Alzheimer Disease. Circ Res. 2019 01 04; 124(1):142-149.
    View in: PubMed
    Score: 0.006
  20. Pre-amyloid oligomers budding:a metastatic mechanism of proteotoxicity. Sci Rep. 2016 10 24; 6:35865.
    View in: PubMed
    Score: 0.005
  21. Cell geometry and contractile abnormalities of myocytes from failing human left ventricle. Cardiovasc Res. 1995 Aug; 30(2):281-90.
    View in: PubMed
    Score: 0.005
  22. Response to letter regarding article "Inositol 1,4,5-trisphosphate receptors and human left ventricular myocytes". Circulation. 2014 May 27; 129(21):e510-1.
    View in: PubMed
    Score: 0.004
  23. Gene expression and genetic variation in human atria. Heart Rhythm. 2014 Feb; 11(2):266-71.
    View in: PubMed
    Score: 0.004
  24. Coexistence of functioning beta 1- and beta 2-adrenoceptors in single myocytes from human ventricle. Circulation. 1993 Sep; 88(3):854-63.
    View in: PubMed
    Score: 0.004
  25. Stanniocalcin1 is a key mediator of amyloidogenic light chain induced cardiotoxicity. Basic Res Cardiol. 2013 Sep; 108(5):378.
    View in: PubMed
    Score: 0.004
  26. Inositol 1, 4, 5-trisphosphate receptors and human left ventricular myocytes. Circulation. 2013 Sep 17; 128(12):1286-97.
    View in: PubMed
    Score: 0.004
  27. Atrial natriuretic peptide is negatively regulated by microRNA-425. J Clin Invest. 2013 Aug; 123(8):3378-82.
    View in: PubMed
    Score: 0.004
  28. Pathological role of serum- and glucocorticoid-regulated kinase 1 in adverse ventricular remodeling. Circulation. 2012 Oct 30; 126(18):2208-19.
    View in: PubMed
    Score: 0.004
  29. Cardiomyogenesis in the aging and failing human heart. Circulation. 2012 Oct 09; 126(15):1869-81.
    View in: PubMed
    Score: 0.004
  30. Cardiac angiogenic imbalance leads to peripartum cardiomyopathy. Nature. 2012 May 09; 485(7398):333-8.
    View in: PubMed
    Score: 0.004
  31. [Isolated cardiac myocytes: preparation and use in experimental cardiology]. Cardiologia. 1991 Apr; 36(4):319-29.
    View in: PubMed
    Score: 0.004
  32. The ephrin A1-EphA2 system promotes cardiac stem cell migration after infarction. Circ Res. 2011 Apr 29; 108(9):1071-83.
    View in: PubMed
    Score: 0.004
  33. Human cardiac stem cell differentiation is regulated by a mircrine mechanism. Circulation. 2011 Mar 29; 123(12):1287-96.
    View in: PubMed
    Score: 0.004
  34. Regulation of Abro1/KIAA0157 during myocardial infarction and cell death reveals a novel cardioprotective mechanism for Lys63-specific deubiquitination. J Mol Cell Cardiol. 2011 Apr; 50(4):652-61.
    View in: PubMed
    Score: 0.004
  35. Myocyte turnover in the aging human heart. Circ Res. 2010 Nov 26; 107(11):1374-86.
    View in: PubMed
    Score: 0.003
  36. Neonatal gene transfer of Serca2a delays onset of hypertrophic remodeling and improves function in familial hypertrophic cardiomyopathy. J Mol Cell Cardiol. 2010 Dec; 49(6):993-1002.
    View in: PubMed
    Score: 0.003
  37. Independent susceptibility markers for atrial fibrillation on chromosome 4q25. Circulation. 2010 Sep 07; 122(10):976-84.
    View in: PubMed
    Score: 0.003
  38. Cardiomyogenesis in the adult human heart. Circ Res. 2010 Jul 23; 107(2):305-15.
    View in: PubMed
    Score: 0.003
  39. Defective DNA replication impairs mitochondrial biogenesis in human failing hearts. Circ Res. 2010 May 14; 106(9):1541-8.
    View in: PubMed
    Score: 0.003
  40. Amyloidogenic light chains induce cardiomyocyte contractile dysfunction and apoptosis via a non-canonical p38alpha MAPK pathway. Proc Natl Acad Sci U S A. 2010 Mar 02; 107(9):4188-93.
    View in: PubMed
    Score: 0.003
  41. Rescue of Ca2+ overload-induced left ventricular dysfunction by targeted ablation of phospholamban. Am J Physiol Heart Circ Physiol. 2009 Feb; 296(2):H310-7.
    View in: PubMed
    Score: 0.003
  42. Compartmentalized expression of three novel sarco/endoplasmic reticulum Ca2+ATPase 3 isoforms including the switch to ER stress, SERCA3f, in non-failing and failing human heart. Cell Calcium. 2009 Feb; 45(2):144-54.
    View in: PubMed
    Score: 0.003
  43. Fingerprint profile of alcohol-associated heart failure in human hearts. Alcohol Clin Exp Res. 2008 May; 32(5):814-21.
    View in: PubMed
    Score: 0.003
  44. Human cardiac-specific cDNA array for idiopathic dilated cardiomyopathy: sex-related differences. Physiol Genomics. 2008 Apr 22; 33(2):267-77.
    View in: PubMed
    Score: 0.003
  45. Periostin induces proliferation of differentiated cardiomyocytes and promotes cardiac repair. Nat Med. 2007 Aug; 13(8):962-9.
    View in: PubMed
    Score: 0.003
  46. Histidine-rich Ca-binding protein interacts with sarcoplasmic reticulum Ca-ATPase. Am J Physiol Heart Circ Physiol. 2007 Sep; 293(3):H1581-9.
    View in: PubMed
    Score: 0.003
  47. Relationship of volumetric bone mineral density and structural parameters with ERalpha gene polymorphisms. Calcif Tissue Int. 2007 May; 80(5):307-15.
    View in: PubMed
    Score: 0.003
  48. FokI polymorphism of the vitamin D receptor gene correlates with parameters of bone mass and turnover in a female population of the Italian island of Lampedusa. Calcif Tissue Int. 2007 Jan; 80(1):15-20.
    View in: PubMed
    Score: 0.003
  49. SERCA2a in heart failure: role and therapeutic prospects. J Bioenerg Biomembr. 2005 Dec; 37(6):375-80.
    View in: PubMed
    Score: 0.002
  50. PI3K rescues the detrimental effects of chronic Akt activation in the heart during ischemia/reperfusion injury. J Clin Invest. 2005 Aug; 115(8):2128-38.
    View in: PubMed
    Score: 0.002
  51. Transgenic models of heart failure: elucidation of the molecular mechanisms of heart disease. Heart Fail Clin. 2005 Jul; 1(2):219-36.
    View in: PubMed
    Score: 0.002
  52. Antisense strategies for treatment of heart failure. Methods Mol Med. 2005; 106:69-82.
    View in: PubMed
    Score: 0.002
  53. Genetic maneuvers to ameliorate ventricular function in heart failure: therapeutic potential and future implications. Expert Rev Cardiovasc Ther. 2005 Jan; 3(1):85-97.
    View in: PubMed
    Score: 0.002
  54. Passive stiffness changes caused by upregulation of compliant titin isoforms in human dilated cardiomyopathy hearts. Circ Res. 2004 Oct 01; 95(7):708-16.
    View in: PubMed
    Score: 0.002
  55. Cardiac-specific gene expression facilitated by an enhanced myosin light chain promoter. Mol Imaging. 2004 Apr; 3(2):69-75.
    View in: PubMed
    Score: 0.002
  56. Gene transfer in cardiac myocytes. Surg Clin North Am. 2004 Feb; 84(1):141-59, ix-x.
    View in: PubMed
    Score: 0.002
  57. Gene therapy for the treatment of heart failure--calcium signaling. Semin Thorac Cardiovasc Surg. 2003 Jul; 15(3):268-76.
    View in: PubMed
    Score: 0.002
  58. Functional near-infrared fluorescence imaging for cardiac surgery and targeted gene therapy. Mol Imaging. 2002 Oct; 1(4):365-77.
    View in: PubMed
    Score: 0.002
  59. Titin isoform switch in ischemic human heart disease. Circulation. 2002 Sep 10; 106(11):1333-41.
    View in: PubMed
    Score: 0.002
  60. Type 1 phosphatase, a negative regulator of cardiac function. Mol Cell Biol. 2002 Jun; 22(12):4124-35.
    View in: PubMed
    Score: 0.002
  61. Targeting Ca2+ cycling proteins and the action potential in heart failure by gene transfer. Basic Res Cardiol. 2002; 97 Suppl 1:I136-45.
    View in: PubMed
    Score: 0.002
  62. Differential activation of signal transduction pathways in human hearts with hypertrophy versus advanced heart failure. Circulation. 2001 Feb 06; 103(5):670-7.
    View in: PubMed
    Score: 0.002
  63. Prospects for gene therapy for heart failure. Circ Res. 2000 Mar 31; 86(6):616-21.
    View in: PubMed
    Score: 0.002
  64. Protection of human myocardium in vitro by K(ATP) activation with low concentrations of bimakalim. J Cardiovasc Pharmacol. 1999 Jul; 34(1):162-72.
    View in: PubMed
    Score: 0.002
  65. From overload to failure: what happens inside the myocyte. Ann Med. 1998 Aug; 30 Suppl 1:14-23.
    View in: PubMed
    Score: 0.001
  66. Angiotensin II and contraction of isolated myocytes from human, guinea pig, and infarcted rat hearts. Am J Physiol. 1996 Jun; 270(6 Pt 2):H2060-9.
    View in: PubMed
    Score: 0.001
  67. Acceleration of contraction by beta-adrenoceptor stimulation is greater in ventricular myocytes from failing than non-failing human hearts. Basic Res Cardiol. 1996; 91 Suppl 2:53-6.
    View in: PubMed
    Score: 0.001
  68. Sensitization of human atrial 5-HT4 receptors by chronic beta-blocker treatment. Circulation. 1995 Nov 01; 92(9):2526-39.
    View in: PubMed
    Score: 0.001
  69. Reduced contractile responses to forskolin and a cyclic AMP analogue in myocytes from failing human ventricle. Eur J Pharmacol. 1992 Nov 13; 223(1):39-48.
    View in: PubMed
    Score: 0.001
  70. Isolated ventricular myocytes from failing and non-failing human heart; the relation of age and clinical status of patients to isoproterenol response. J Mol Cell Cardiol. 1992 May; 24(5):549-64.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.